Objective:

To provide updated recommendations for breast cancer screening in asymptomatic, average-risk adult female patients, emphasizing the importance of individualized care.

Approach:

Key Findings:

• Biennial mammography is recommended for women aged 50 to 74 years, with evidence of reduced breast cancer mortality.
• Shared decision-making is emphasized for women aged 40 to 49 years, considering individual risk factors.
• No clear mortality benefit from screening for women aged 75 years and older, particularly those with limited life expectancy.
• DBT may be beneficial for women with dense breasts, but MRI and ultrasound are not recommended due to higher false-positive rates and lack of mortality reduction.

Interpretation:

The updated guidance aims to balance the benefits and harms of breast cancer screening, emphasizing individualized patient care and informed decision-making based on specific age groups and risk factors.

Limitations:

• Limited data for patients aged 40 to 49 years and those aged 75 years or older, which may affect the applicability of recommendations.
• Lack of mortality data for supplemental screening modalities, limiting the ability to assess their effectiveness.
• Uncertainty regarding optimal screening intervals, which may impact patient outcomes.

Conclusion:

The ACP's recommendations focus on tailored screening approaches to minimize harms while maximizing benefits for average-risk women, highlighting the importance of shared decision-making.

Sources:

• Annals of Internal Medicine
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.